Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NX 211

Known as: NX-211, NX211, NX211 cpd 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
BACKGROUND OSI-211 (also known as NX211) is a liposomal preparation of the topoisomerase I inhibitor, lurtotecan, which has shown… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
This study was aimed at characterizing the role of BCRP/MXR/ABCP (BCRP) in resistance of the human ovarian tumor cell lines T8… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2001
2001
Prolonging tumor exposure to topoisomerase I inhibitors has been correlated to enhance the efficacy of those agents. Lurtotecan… Expand
Is this relevant?
2000
2000
Lurtotecan (GI147211; LRT) is a semisynthetic and water-soluble analogue of the topoisomerase I inhibitor camptothecin. To… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Lurtotecan is a clinically active water-soluble camptothecin analogue that has been formulated into a low-clearance unilamellar… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?